baber/WOPTO huggingface dataset:
Patent DE-69123737-D1 (DE)
Inventor: ROGERS BOBBY E
IPC: A61M39/02
Filed: 1991-04-09
Granted: 1997-01-30
Abstract: A medical valve assembly is described in which the valve assembly has a female luer lock portion on an inlet end of the device and a male luer lock portion on the outlet portion of the valve. A movable piston seals the inlet portion of the valve from the outlet portion when the piston is in the closed position. When a syringe is attached to the inlet portion of the valve assembly, the piston is displaced in a manner that unseals a fluid channel inlet. This connects the end of the syringe to the fluid channel which is connected, at its outlet end, to a catheter or other device, connected to a patient. Thus, medication can be introduced to, or fluids aspirated from, a patient's bloodstream, without the use of a syringe having a needle. When the syringe is removed from the inlet to the valve assembly, the piston is urged by a biasing means into its original closed position creating a seal between the inlet portion of the valve and the outlet portion of the valve. This feature maintains catheter patency. The top surface of the piston along with the area of the female luer lock connector does not have any fluid reservoir and can be easily cleaned to prevent the possibility of bacterial infection as a result of repeated uses of the valve assembly.
Patent DE-69125467-D1 (DE)
Inventor: KANAKA KEIICHI
IPC: C08G63/183
Filed: 1991-12-23
Granted: 1997-05-07
Abstract: A moldable polyester resin of the polycyclohexylenedimethylene terephthalate type and having improved thermal stability in the molten state is provided by   (a) an aromatic dicarboxylic acid or its ester-forming derivative, and (b) an aliphatic dihydroxy compound comprising at least 35 mole % of 1,4-cyclohexanedimethanol, which resin is produced by copolymerizing components (a) and (b) with   (c) an ester-forming diol compound of the following general formula HO-R-0-A-0-R-OH (I) in such an amount that 0.1 to 30 mole % thereof, based on the aromatic dicarboxylic acid group, is introduced thereinto, wherein A in formula (I) represents a divalent organic radical having at least one aromatic ring and R represents a divalent organic radical selected from among aliphatic hydrocarbon groups having 2 to 8 carbon atoms and polyoxyalkylene groups. l
Patent DE-69126862-D1 (DE)
Inventor: PETTIGREW ARCHIBALD
IPC: H03G3/30
Filed: 1991-01-23
Granted: 1997-08-21
Abstract: PCT No. PCT/GB91/00101 Sec. 371 Date Jul. 22, 1992 Sec. 102(e) Date Jul. 22, 1992 PCT Filed Jan. 23, 1991 PCT Pub. No. WO91/11854 PCT Pub. Date Aug. 8, 1991.There is described an electronic circuit which operates an Amplitude Locked Loop. The circuit comprises a voltage controlled amplifier, a modulus detector and an integrator combined in a feedback loop. An FM signal decoder is also described as are a number of applications of Amplitude Locked Loop.
Patent DE-69128825-D1 (DE)
Inventor: OHKAWA TAKAYUKI -
IPC: D06F43/08
Filed: 1991-04-25
Granted: 1998-03-05
Abstract: Heated air is delivered into a drying chamber, a solvent contained in an article to be dried which is housed in a drying drum in the drying chamber is evaporated together with moisture, this air containing the vapor of solvent and the moisture is cooled and the moisture and the vapor of solvent are separated in liquefied conditions. An air blower (5) is provided in an exhaust path (6) of the drying chamber (1) provided with a drying drum (2). A heating chamber (11) is provided in an air intake path (8) of the drying chamber (1). A cooling chamber (14) communicating with a solvent recovery path (15) is allowed to communicate with the air intake path (8) and the exhaust path (6), to thereby form a solvent recovery circulating path (25). An openable outdoor air introducing opening (21) for introducing outdoor air is provided in the air intake path (8). A change-over damper (24) for selectively allowing the air intake path (8) to communicate with an air exhaust path on the side of the outdoor air is provided on the side of outlet of the cooling chamber. The vapor of solvent contained in the exhausted air can be recovered as much as possible to be released to the atmosphere in a low odor condition.
Patent DE-69132937-D1 (DE)
Inventor: SIMS JOHN
IPC: C12N5/10
Filed: 1991-05-24
Granted: 2002-04-04
Abstract: Type II IL-1 receptor (type II IL-1R) proteins, DNAs and expression vectors encoding type II IL-1R, and processes for producing type II IL-1R as products of recombinant cell culture, are disclosed. <IMAGE>
Patent DE-69207428-D1 (DE)
Inventor: BLONK DIRK
IPC: C22B5/16
Filed: 1992-10-27
Granted: 1996-02-15
Abstract: PCT No. PCT/NL92/00191 Sec. 371 Date Apr. 22, 1994 Sec. 102(e) Date Apr. 22, 1994 PCT Filed Oct. 27, 1992 PCT Pub. No. WO93/08936 PCT Pub. Date May 13, 1993.A method for removing one or more contaminations from a bulk material, the bulk material being fed into a treating chamber (1), exposed therein to a temperature treatment and then discharged. According to the invention, the bulk material is exposed to a vacuum treatment during temperature treatment. An apparatus according to the invention for the implementation of the method comprises a treating chamber (1) for treating contaminated bulk material therein, feeding means (2) for feeding the bulk material to the treating chamber (1), discharging means (9) for discharging the bulk material from the treating chamber and heating means (19) for heating the bulk material in the treating chamber. The apparatus also includes a vacuum forming means (16) for forming a vacuum in the treating chamber.
Patent DE-69209916-D1 (DE)
Inventor: GALLI ANGELI DEPALMO
IPC: A61K31/496
Filed: 1992-07-18
Granted: 1996-05-23
Abstract: In an improved solid pharmaceutical composition for oral administration consisting of or made from a granulate comprising dapiprazole or a physiologically acceptable acid addition salt thereof together with at least one pharmaceutically acceptable inert excipient; the improvement comprises adding to said granulate a level of magnesium oxide capable of preventing or substantially reducing the degradation of dapiprazole or of the acid addition salt thereof.
Patent DE-69210821-D1 (DE)
Inventor: TROUGOUBOFF EMILE
IPC: E01F13/08
Filed: 1992-06-12
Granted: 1996-06-20
Abstract: PCT No. PCT/FR92/00531 Sec. 371 Date Mar. 7, 1994 Sec. 102(e) Date Mar. 7, 1994 PCT Filed Jun. 12, 1992 PCT Pub. No. WO92/22709 PCT Pub. Date Dec. 23, 1992.A barrier for the protection of reserved areas including at least one upper element (1) rotatably mounted relative to a lower element (6) anchored in the ground (G). An elastic return spring (18) is interposed between the upper and lower elements (1,6). The upper element (1) is adapted to be displaced to either side of an upright reference position by rotating about a horizontal pin (2) provided on the lower element (6). A releasable mechanism selectively blocks rotation of the upper element in a first direction (F2) and a non-releasable mechanism blocks rotation of the upper element in the reverse direction (F1) at the end of a limited angular deflection. The elastic return spring provides a force opposing the limited deflection in the reverse direction.
Patent DE-69217409-D1 (DE)
Inventor: LAYDEN JOHN E
IPC: G05B19/418
Filed: 1992-05-11
Granted: 1997-03-27
Abstract: A system for monitoring a multiparameter manufacturing process by examining on a real-time basis a stream of data units, each data unit including a numerical characteristic indicative of a current state of one of the parameters of that manufacturing process and a tag identifying the parameter. The system employs an entity-relational database to group and evaluate all data units using statistical evaluation criteria, and to identify and generate signals relating to particular testpoints in the manufacturing process so that an indication of the significance of the statistical pattern and the manufacturing process parameter involved are given in such terms as to permit human evaluation of and, if necessary, manual or automatic intervention in the manufacturing process. <IMAGE>
Patent DE-69228452-D1 (DE)
Inventor: STELTENKAMP ROBERT J
IPC: A47L15/00
Filed: 1992-07-23
Granted: 1999-04-01
Abstract: An aqueous liquid detergent composition is provided for cleaning a hard surface and for repelling insects therefrom comprising a detersive proportion of a surface active detergent compound, an effective amount of at least one of certain defined insect repellent materials which is sufficient to repel insect from the hard surface after application of the detergent composition thereto, the liquid detergent composition being substantially free of a liquid hydrocarbon. <IMAGE>
Patent DE-69233691-D1 (DE)
Inventor: OSHLACK BENJAMIN
IPC: A61K47/44
Filed: 1992-11-25
Granted: 2007-06-06
Abstract: (A) Controlled release oxycodone formulation for oral admin. to human patients, comprises (i) 10-40mg oxycodone or its salt, the formulation providing a mean max. plasma conc. of oxycodone of 6-60 ng/ml from a mean of 2-4.5 hrs.. After admin., and a mean min. plasma conc. of 3-30 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady state conditions. (ii) 10-160 mg oxycodone or its salt, the formulation providing a mean max. plasma conc. of oxycodone of 6-240 ng/ml from a mean of 2-4.5 hrs. after admin., and a mean min. plasma conc. from 3-120 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady-state conditions. (B) Also claimed is a solid controlled release oral dosage form comprising (i) oxycodone or its salt in amt. of 10-160 mg; a controlled release matrix selected from hydrophilic hydrophobic polymers, digestible opt. substd. 8-50C hydrocarbons, and/or polyalkylene glycols; and a diluent; wherein the compsn. provides a mean max. plasma conc. of oxycodone of 6-240 ng/ml from a mean of 2-4.5 hrs. after admin, and mean min. plasma conc. of 3-120 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady-state conditions; or (ii) an analgesically effective amt. of spheroids comprising oxycodone or its salt and either a spheronising agent or an acrylic polymer or copolymer, such that the total dosage of oxycodone in the dosage form is 10-160 mg; a film coating which controls the release of the oxycodone or its salt at a controlled rate in an aq. medium, wherein the compsn. provides an in vitro dissolution rate of the dosage form.
Patent DE-69318733-D1 (DE)
Inventor: VELIE WALLACE W
IPC: F16K31/08
Filed: 1993-03-25
Granted: 1998-06-25
Abstract: A magnetically operated excess flow check valve which permits fluid flow through a line when the flow is below a predetermined flow rate but shuts the flow if the flow rate rises above the predetermined limit to prevent uncontrolled flow or discharge of fluids such as might occur if a fluid line is ruptured including unique packaging or mounting of the excess flow check valve in a capsule to facilitate its installation in various flow lines, fittings, pipe systems, appliances and the like. The packaging is in the form of a self contained capsule which can be inserted in various flow passageways with the capsule facilitating assembly of the individual components into a self contained compact package.
Patent DE-69319719-D1 (DE)
Inventor: STRAUS JAROSLAV
IPC: A61B18/02
Filed: 1993-03-22
Granted: 1998-08-20
Abstract: PCT No. PCT/CZ93/00004 Sec. 371 Date Sep. 22, 1994 Sec. 102(e) Date Sep. 22, 1994 PCT Filed Mar. 22, 1993 PCT Pub. No. WO93/18714 PCT Pub. Date Sep. 30, 1993A method of carrying out cryosurgical interventions includes cooling biological tissue at a rate of at least 180 K/min to a temperature of -190 DEG  C. to -160 DEG  C., subsequently rewarming the biological tissue at a rate of 100 to 240 K/min to a temperature of -70 DEG  C. to -20 DEG  C. with a subsequent rewarming at a rate of 10 to 25 K/min to a temperature of -5 DEG  C. to +5 DEG  C., and further rewarming the biological tissue up to body temperature. The total time of the controlled rewarming of the biological tissue is shorter than 5 minutes. An apparatus for carrying out the method of cryosurgical interventions includes a container of cooled medium an operating instrument, and a control unit for controlling the cooling and subsequent rewarming of biological tissue. The control unit includes a microprocessor coupled to electronic switches and a measuring unit.
Patent DE-69321845-D1 (DE)
Title: Hydroxyethylaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
Inventor: VAZQUEZ MICHAEL
IPC: C07D233/54
Filed: 1993-08-24
Granted: 1998-12-03
Abstract: The present invention provides retroviral protease inhibitor compounds represented by the Formula I: <CHEM>   Such compounds are urseful for preparing medicaments for inhibiting proteases, especially for inhibiting HIV protease and for treating a retroviral infection such as HIV infection and for treating AIDS.
Patent DE-69331994-D1 (DE)
Inventor: CHEN JANE-JANE
IPC: C12N9/12
Filed: 1993-08-27
Granted: 2002-07-11
Abstract: The cDNA which encodes heme-regulated eIF-2 alpha  kinase (HRI) has been cloned from a lambda Zap II cDNA library of rabbit reticulocytes. The rabbit HRI cDNA is highly homologous to human HRI and hybridizes to the human HRI DNA under moderately stringent conditions. The rabbit HRI cDNA contains 2729 amino acids. In vitro translation of HRI mRNA transcribed from HRI cDNA yields a 90 kDa polypeptide with eIF-2 alpha  kinase activity. Since HRI is a potent inhibitor of protein synthesis, it is anti-proliferative in nature. In addition, the unusually high degree of homology of HRI to three protein kinases involved in the regulation of cell division suggests that HRI plays a direct role in the regulation of cell division. Since regulation of protein synthesis is vital for cell growth and differentiation, the cDNA can be inserted into cells to manipulate proliferation and differentiation, especially of cells that are proliferating in an uncontrolled manner or characterized by arrested differentiation, such as some of the types of cancers. Deletion mutants of HRI cDNA can be constructed that are insensitive to regulation by heme, which should be more effective than native HRI in its anti-viral and anti-proliferative action.
Patent DE-69333537-D1 (DE)
Inventor: ANDERSEN ANDERS JORGEN
IPC: A61K47/48
Filed: 1993-03-29
Granted: 2004-07-01
Abstract: Peptide T and its linear or cyclic analogues of the General Formula 1: I-A-B-C-D-E-F-G-H-II wherein     A is Ala, Gly, Val, Ser, Thr or absent;   B is Ala, Gly, Val, Ser, Thr or absent;   C is Ser, Thr or absent;   D is Ser, Thr, Asn, Glu, Arg, Ile, Leu or absent;   E is Ser, Thr, Asp or absent;   F is Thr, Ser, Asn, Arg, Gln, Lys, Trp or absent;   G is Tyr or absent;   H is Thr, Arg, Gly, Met, Met(O), Cys, Thr, Gly or absent;  and   I is Cys or absent; II is Cys, an amide group, substituted amide group, an ester group or absent; at least one of the amino acids optionally being substituted by a monomeric or polymeric carbohydrate or derivative thereof, such substitution being accomplished through hydroxyl and/or amino and/or amido groups of the amino acids, comprising at least 4 amino acids, and their pharmaceutically acceptable salts, are useful in the treatment or prevention of inflammation. In particular, the peptides are useful in the treatment or prevention of multiple sclerosis, myelopathies (including HTLV-1 associate myelopathy) and symptoms and diseases associated with chronic immune activation, including chronic fatigue syndrome, toxic shock, arthritis, inflammatory bowel disease and host-versus-graft and graft-versus-host responses in transplant recipients.
Patent DE-69401063-D1 (DE)
Inventor: KJAERGAARD FINN
IPC: D04B1/24
Filed: 1994-05-03
Granted: 1997-01-16
Abstract: PCT No. PCT/DK94/00175 Sec. 371 Date Nov. 2, 1995 Sec. 102(e) Date Nov. 2, 1995 PCT Filed May 3, 1994 PCT Pub. No. WO94/24978 PCT Pub. Date Nov. 10, 1994A fixation panty brief (7, 29) comprises a tubular body portion (10) and a crotch portion (11). The panty brief comprises a waistband portion (16) for encircling the body of the user and at the same time a snug fit to the user known from ordinary circular knitted panty briefs. The body portion (10) and the crotch portion (11) of the fixation panty brief are produced in one singular piece by circular knitting and at the same time a looser knitting has been used in one or several areas for providing containment and fixation pockets (21, 30) for containing a diaper or hip protection bowls which are held in place in that the delimiting edge areas have an elastic and firm knitting which forms a close fit to the user's body. The edge areas will consequently be in firm contact with the user's body while the pockets (21, 30) are able to contain a diaper or a hip protection bowl. A panty brief may also comprise a loose net-like structure for providing an inspection window (5). In this manner it is possible to see a moisture indicator on a diaper (20). The panty brief is advantageous in that it provides rich user comfort and may be manufactured with a very low degree of afterfashioning.
Patent DE-69408464-D1 (DE)
Inventor: LE LETTY RONAN
IPC: H02N2/16
Filed: 1994-08-17
Granted: 1998-03-12
Abstract: PCT No. PCT/EP94/02732 Sec. 371 Date Jan. 31, 1996 Sec. 102(e) Date Jan. 31, 1996 PCT Filed Aug. 17, 1994 PCT Pub. No. WO95/05682 PCT Pub. Date Feb. 23, 1995Traveling-wave piezoelectric motor comprising at least one rotor (20, 21), at least one annular stator (27, 28) and two groups of piezoelectric elements (29) dispersed around the stator, in permanent contact with the stator and excited by an alternating current with a  pi /2 phase shift between the groups so as to produce, at the surface of the stator, a traveling wavelike deformation. Piezoelectric elements consist of mutually independent polarized ceramic bars (29) arranged perpendicularly to the stator and each connected to the stator by an articulation (14).
Patent DE-69415981-D1 (DE)
Inventor: FIELDING DENNIS
IPC: H04B7/185
Filed: 1994-06-16
Granted: 1999-02-25
Abstract: A frame relay protocol-based earth station interface architecture provides full mesh connectivity for a relatively small number of network stations. The fundamental component of the architecture is a frame relay protocol-based switch (110), which employs a network interface "frame relay" standard to define the muliplexing of multiple virtual ports across single physical communications port. Through address and control fields of its connectivity control software, the frame relay protocol-based switch (110) can be dynamically configured to provide multilayer addressing and device selectivity, thereby enabling point-to-point connectivity of multiple terminal devices, such as a plurality of audio circuits (170-1...170-N), to be effected via a single port. Dial codes on the station side of an audio signal muliplexer link (135) are translated into frame relay addresses (data link connection identifiers) that are added to each frame of data for routing though the network. <IMAGE>
Patent DE-69421315-D1 (DE)
Inventor: MENASHE JULIAN
IPC: G06F19/00
Filed: 1994-05-18
Granted: 1999-12-02
Abstract: The gaming system includes a host computer, a plurality of general purpose terminal computers forming player stations remote from the host, means for providing communication between each of the terminals and the host. Each terminal has a program for generating screen graphics and sound locally in response to control data packets generated by and received from the host. The host generates random numbers for a game being played on a connected terminal within preset criteria for that game in response to data packets received from the terminal. The data packets are of variable length between 1 and 80 bytes. The host sequentially stores the minimum significant information for replaying a game, auditing and security, such as accounting data of each player at the start of each game, random numbers generated by the host, responses received from a player, and whether a game was completed. Play is substantially real-time, because only minimal data is transmitted with functions requiring large amounts of data, such as screen graphics being generated locally. The statuses of host and terminal are restored automatically on re-establishing communication following an interruption to ensure fairness to players and prevent them defeating the outcome of a game.   <IMAGE>
Patent DE-69422984-D1 (DE)
Inventor: SOEDERHOLM NILS
IPC: D21F1/48
Filed: 1994-06-10
Granted: 2000-03-16
Abstract: PCT No. PCT/FI94/00250 Sec. 371 Date Mar. 6, 1996 Sec. 102(e) Date Mar. 6, 1996 PCT Filed Jun. 10, 1994 PCT Pub. No. WO94/29519 PCT Pub. Date Dec. 22, 1994An apparatus in a paper or board machine for dewatering a web carried along a first wire section and prior to introduction of the web to a press section of the paper or board machine. The apparatus comprises a first pair of water removing rolls for receiving the web and the first wire section which include a non-suction water receiving roll which is mounted on a first side of the web and has an open surface for receiving and temporarily holding water removed from the web, and a non-suction smooth surfaced roll mounted on the second side of the web. A second permeable wire section is brought in contact with a side of the web opposite that of the first wire section while passing through the pair of rolls. The first and second wire sections produce a press nip when they pass through the pair of water removing rolls with the web to remove water from the web, the water being removed to openings in the open surface of the non-suction water receiving roll. A water receptacle is positioned just downstream of the pair of water removing rolls on the same side of the web as the non-suction water receiving roll for collecting water as water is thrown from the non-suction water receiving roll by centrifugal force produced from rotation. A transfer device for transferring the web traveling on and supported by the first wire section as a closed draw to the press section.
Patent DE-69427666-D1 (DE)
Inventor: MORRIS JAMES C
IPC: A61F5/01
Filed: 1994-02-08
Granted: 2001-08-16
Abstract: An ankle brace having a rigidifying and unitizing external shell (12) comprising a unitary member made of a rigid material and including a leg encircling portion at least substantially encircling the lower leg of the wearer and ankle stays (34,36) extending downwardly from the leg encircling portion over the ankle and down to the heel on both the medial and lateral sides of the leg, the leg encircling portion accommodating flexing of the sides of the shell about a vertical axis intermediate the ankle stays for movement of the sides and the stays horizontally into supporting engagement with the medial and lateral sides of the leg and ankle, the shell preventing undesired movement of the ankle stays relative to one another. The ankle brace also features a metatarsal support (20) extending from the region of the metatarsals over the lateral side and instep of the wearer's foot to the medial side of the shell, where the shell provides a rigid post for anchoring the metatarsal support. <IMAGE>
Patent DE-69430233-D1 (DE)
Inventor: MCDONNELL PATRICK FRANCIS
IPC: C09J/
Filed: 1994-12-22
Granted: 2002-05-02
Abstract: A curable cyanoacrylate adhesive composition intended for medical and/or veterinary uses is sterilized in liquid form by gamma irradiation. The composition comprises     a) a cyanoacrylate monomer b) a combination of an anionic stabilizer and a free-radical stabilizer in amounts effective to stabilize the composition during irradiation and to stabilize the sterilized composition during storage prior to cure, wherein the free radical stabilizer is a selected phenolic antioxidant (but not including hydroquinone).   The preferred free radical stabilizer is butylated hydroxyanisole. After irradiation the cyanoacrylate monomer is substantially ungelled.